Eric Weinberg is CCO at RxSight, Inc. (RXST). They have made 4 open-market trades across 1 company since 2021, most recently 2026-09-15.
CIK 0001295814
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $515K since 2021, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXST | 235,516 | $1.1M |
| ILSE | 182,952 | — |
| Total | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-16 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXST | SELL | 2026-09-02 | 2026-09-02 | $6.96 | $14K | -20.5% | -33.5% | — |
| RXST | SELL · 10b5-1 | 2024-02-01 | 2024-02-02 | $50.00 | $500K | +10.1% | +18.5% | +26.1% |
| RXST | SELL · 10b5-1 | 2024-01-22 | 2024-01-22 | $48.00 | $480K | +5.3% | +16.2% | +10.7% |
| RXST | SELL · 10b5-1 | 2024-01-09 | 2024-01-10 | $46.00 | $460K | +1.1% | +6.8% | +18.2% |
| RXST | SELL · 10b5-1 | 2024-01-08 | 2024-01-09 | $42.00 | $420K | +2.9% | +6.3% | +22.3% |
| RXST | SELL | 2023-12-22 | 2023-12-26 | $40.00 | $51K | +14.6% | +19.5% | +23.9% |
| RXST | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $40.01 | $697K | -6.0% | +18.9% | +19.9% |
| RXST | BUY | 2021-08-03 | 2021-08-05 | $16.00 | $500K | -14.4% | +14.4% | -6.6% |
| RXST | BUY | 2021-07-30 | 2021-08-06 | $16.47 | $15K | -7.4% | +18.9% | -3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.